STEMLINE THERAPEUTICS INC
STEMLINE THERAPEUTICS INC (STML) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 206 transactions totaling $13.6M, demonstrating a bearish sentiment with -$13.3M in net insider flow. The most recent transaction on Jun 10, 2020 involved a transaction of 60,121 shares valued at $0.
STML Insider Activity Summary
Who Is Buying STML Stock?
No significant insider buying has been recorded for STML in the recent period.
Who Is Selling STML Stock?
No significant insider selling has been recorded for STML in the recent period.
Is STEMLINE THERAPEUTICS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for STML is bearish with an Insider Alignment Score of 1/100 and a net flow of -$13.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
STML Frequently Asked Questions
Understanding STML Insider Activity
Insider trading at STEMLINE THERAPEUTICS INC (STML) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading STML stock, having executed 206 transactions in the past 90 days. The most active insider is Kenneth Hoberman (Executive), who has made 63 transactions totaling $6.0M.
Related Tools
Track STEMLINE THERAPEUTICS INC Insider Activity
Get notified when executives and directors at STML file new Form 4 transactions